Publication standards for clinical research sponsored by the pharmaceutical industry;Normas para la publicación de investigaciones clínicas patrocinadas por la industria farmacéutica

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 14, Issue 1, 2003, Pages 62-66

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PHARMACEUTICAL INDUSTRY; STANDARD (REFERENCE);

CLINICAL RESEARCH; CLINICAL STUDY; DRUG INDUSTRY; ETHICS; FINANCIAL MANAGEMENT; HUMAN; LANGUAGE; METHODOLOGY; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; REVIEW; STANDARD;

EID: 0042425964     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1020-49892003000600018     Document Type: Review

References (9)

1. National Bioethics Advisory Commission. Ethical issues in international research: setting the stage. http://www.georgetown.edu/research/nrcbl/nbac/clinical/Chap1.html (Acceso el 20 de junio de 2003).
2. Baird P. Getting it right: industry sponsorship and medical research. [Commentary]. CMAJ 2003;168(10):1267-1269.
3. Lexchin J, Bero LA, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-1170.
4. Council for International Organisations of Medical Sciences (CIOMS). CIOMS Guidelines 2002. http://www.reb.ca/assets/documents/regulations/ciomsguidelines2002.htm (Acceso el 23 de junio de 2003).
5. Council for International Organisations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects, 1993. http://www.reb.ca/assets/documents/ regulations/ciomsinternationalguidelines human1993.htm (Acceso el 23 de junio de 2003).
6. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. [Updated in October 2001]. http://www.icmje.org/index.html (Acceso el 23 de junio de 2003).
7. Davidoff F, DeAngelis CD, Drazen JM, Nicholls M G, Hoey J, Højgaard L, et al. Sponsorship, authorship and accountability. 2001; CMAJ;165(6):786-788.
8. Wager L, Field EA, Grossman L. Good publication practice for pharmaceutical companies. CMRO 2003;19(3):149-154.
9. Moher D, Schulz KF, Altman DG para The CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials 2001. http:// www.consort-statement.org/ (Acceso el 23 de junio de 2003).